Regulating Homeopathic Drugs: Pragmatic Solutions for the Food and Drug Administration

DSpace/Manakin Repository

Regulating Homeopathic Drugs: Pragmatic Solutions for the Food and Drug Administration

Show simple item record

dc.contributor.advisor Hutt, Peter Barton en_US
dc.contributor.author Gelfond, Rebecca J. en_US
dc.date.accessioned 2012-06-07T04:25:14Z
dc.date.issued 1999 en_US
dc.identifier.citation Regulating Homeopathic Drugs: Pragmatic Solutions for the Food and Drug Administration (1999 Third Year Paper) en
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8846788
dc.description.abstract Despite the growth of both the use of homeopathic drugs and the homeopathic drug industry, the Food and Drug Administration (FDA) has not altered its regulatory scheme for homeopathic drugs. As a result, homeopathic drugs are allowed on the market without any evidence that they are either safe or effective. The growing use of homeopathic drugs suggests that the FDA should reconsider its stance on homeopathic drugs so as to ensure consumer safety but yet preserve consumer choice. en
dc.language.iso en_US en
dash.license LAA en_US
dc.subject Food and Drug Law en
dc.subject FDA en
dc.subject regulation en
dc.subject homeopathic en
dc.subject homeopathy en
dc.title Regulating Homeopathic Drugs: Pragmatic Solutions for the Food and Drug Administration en
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-06-07T04:25:14Z

Files in this item

Files Size Format View
Gelfond.pdf 265.3Kb PDF View/Open
Gelfond.rtf 215.2Kb RTF file View/Open
Gelfond.html 177.0Kb HTML View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters